Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tretinoin topical - Phosphagenics

Drug Profile

Tretinoin topical - Phosphagenics

Alternative Names: Retinoic acid topical; TPM-02/retinoic acid; TPM®/tretinoin; Tretinoin/TPM®

Latest Information Update: 30 May 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phosphagenics
  • Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
  • Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Acne vulgaris

Highest Development Phases

  • Phase II Acne vulgaris

Most Recent Events

  • 30 May 2016 Tretinoin topical - Phosphagenics is available for licensing in World as of 30 May 2016. http://www.phosphagenics.com
  • 08 Oct 2014 Phosphagenics completes a phase II trial in Acne vulgaris in Australia and New Zealand (Topical) (ACTRN12613000756729)
  • 07 Oct 2014 Efficacy and adverse event data from a phase II trial in Acne vulgaris released by Phosphagenics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top